Loncar Cancer Immunotherapy ETF — new fund registration

ETF Series Solutions registered 1 new fund series on Form 485APOS, filed 2015-07-06. Featured series: Loncar Cancer Immunotherapy ETF.

Registration

• Registrant / trust: ETF Series Solutions
• CIK: 0001540305
• Form: 485APOS
• Filed: 2015-07-06
• State of incorporation: DE
• Accession: 0000894189-15-003216
• Reported net assets: $8.9M

Series & classes (1)

Fees (from the effective prospectus)

• 12b-1 fee: 0.00%
• Gross expense ratio: 0.79%
• Management fee: 0.79%
• Other expenses: 0.00%

Investment objective

The Range Cancer Therapeutics ETF (the Fund) seeks to track the total return performance, before fees and expenses, of the Range Oncology Therapeutics Index (the Index).

Advisers

• Exchange Traded Concepts, LLC (Advisor)

Other filings by this registrant (15)

• 485APOS — 2026-08-05 (1 new series)
• 485APOS — 2026-07-29 (1 new series)
• 485APOS — 2026-06-29 (1 new series)
• 485APOS — 2026-06-26 (1 new series)
• 485APOS — 2026-06-22
• 485APOS — 2026-05-29 (1 new series)
• 485APOS — 2026-05-27
• 485APOS — 2026-05-27 (1 new series)
• 485APOS — 2026-05-22 (2 new series)
• 485APOS — 2026-05-20 (1 new series)
• 485APOS — 2026-05-20 (4 new series)
• 485APOS — 2026-05-13

More

• Registrant profile: ETF Series Solutions
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search